Crossmark

Commentary on Predictive Factors for Sustained Pain after (sub)acute Osteoporotic Vertebral Fractures. Combined Results from the VERTOS II and VERTOS IV Trial

Crossref DOI link: https://doi.org/10.1007/s00270-022-03237-5

Published Online: 2022-08-03

Published Print: 2022-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Clark, William https://orcid.org/0000-0002-2352-9340
License Information

Text and Data Mining valid from 2022-08-03

Version of Record valid from 2022-08-03
More Information

Article History

Received: 19 July 2022

Accepted: 20 July 2022

First Online: 3 August 2022

Declarations

:

: William Clark was author of the VAPOUR trial which received an unrestricted research grant from CareFusion Corporation.

: Not applicable.

Document is current

Any future updates will be listed below